Table 2. Characteristics of the Study Population, medication, n (%).
|
BMI
|
||||
|---|---|---|---|---|
| Medication | < 25 kg/m2 n=5 (%) | 25-30 kg/m2 n=7 (%) | > 30 kg/m2 n=14 (%) | P for difference |
| Renin-Angiotensin-Blockers | 3 (60%) | 5 (71%) | 13 (93%) | n.s. |
| Statins | 3 (60%) | 6 (86%) | 10 (71%) | n.s. |
| Antiplatelets | 4 (80%) | 6 (86%) | 12 (86%) | n.s. |
| Diuretics | 3 (60%) | 3 (43%) | 11 (79%) | n.s. |
| Calcium Channel Blockers | 3 (60%) | 3 (43%) | 7 (50%) | n.s. |
| Beta-Blockers | 4 (80%) | 4 (57%) | 11 (79%) | n.s. |